PL3615035T3 - Zastosowanie 20-hydroksyekdyzonu i jego pochodnych w leczeniu miopatii - Google Patents

Zastosowanie 20-hydroksyekdyzonu i jego pochodnych w leczeniu miopatii

Info

Publication number
PL3615035T3
PL3615035T3 PL18719583T PL18719583T PL3615035T3 PL 3615035 T3 PL3615035 T3 PL 3615035T3 PL 18719583 T PL18719583 T PL 18719583T PL 18719583 T PL18719583 T PL 18719583T PL 3615035 T3 PL3615035 T3 PL 3615035T3
Authority
PL
Poland
Prior art keywords
hydroxyecdysone
myopathies
derivatives
treatment
Prior art date
Application number
PL18719583T
Other languages
English (en)
Inventor
Pierre Dilda
René LAFONT
Mathilde Latil
Maria Serova
Onnik AGBULUT
Stanislas Veillet
Original Assignee
Biophytis
Sorbonne Université
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophytis, Sorbonne Université filed Critical Biophytis
Publication of PL3615035T3 publication Critical patent/PL3615035T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
PL18719583T 2017-04-28 2018-04-27 Zastosowanie 20-hydroksyekdyzonu i jego pochodnych w leczeniu miopatii PL3615035T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR1753775A FR3065644B1 (fr) 2017-04-28 2017-04-28 Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation
FR1758071A FR3065642B1 (fr) 2017-04-28 2017-08-31 Utilisation de 20-hydroxyecdysone et ses derives dans le traitement des myopathies
PCT/EP2018/060975 WO2018197708A1 (fr) 2017-04-28 2018-04-27 Utilisation de 20-hydroxyecdysone et ses dérivés dans le traitement des myopathies
EP18719583.9A EP3615035B1 (fr) 2017-04-28 2018-04-27 Utilisation de 20-hydroxyecdysone et ses dérivés dans le traitement des myopathies

Publications (1)

Publication Number Publication Date
PL3615035T3 true PL3615035T3 (pl) 2021-12-20

Family

ID=59381456

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18719583T PL3615035T3 (pl) 2017-04-28 2018-04-27 Zastosowanie 20-hydroksyekdyzonu i jego pochodnych w leczeniu miopatii

Country Status (12)

Country Link
US (2) US11542295B2 (pl)
EP (2) EP3615035B1 (pl)
JP (2) JP7295806B2 (pl)
KR (2) KR102652803B1 (pl)
CN (2) CN110769832B (pl)
BR (2) BR112019022379A2 (pl)
DK (1) DK3615036T3 (pl)
ES (1) ES2882571T3 (pl)
FR (2) FR3065644B1 (pl)
PL (1) PL3615035T3 (pl)
PT (2) PT3615035T (pl)
WO (2) WO2018197708A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3065644B1 (fr) * 2017-04-28 2020-02-21 Biophytis Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation
FR3078252B1 (fr) * 2018-02-28 2020-08-14 Biophytis Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation
CZ309080B6 (cs) * 2018-12-19 2022-01-19 Karel Dr. Sláma Způsob stanovení rizika vzniku maligních nádorů
FR3093641B1 (fr) * 2019-03-15 2023-11-03 Biophytis Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de l’altération de la fonction respiratoire
FR3093640B1 (fr) * 2019-03-15 2021-10-01 Biophytis Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de maladies neuromusculaires
FR3108504B1 (fr) 2020-03-30 2023-03-31 Biophytis Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement d’altérations de la fonction respiratoire lors d’une infection virale

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38540A0 (en) * 1971-01-18 1972-03-28 Dauten Sa Method for the extraction of insect moulting steroid hormones
CN1353113A (zh) * 2001-11-29 2002-06-12 沈阳药科大学 中药牛膝有效部位及其制剂与医药用途和制备方法
US8785149B2 (en) * 2010-04-08 2014-07-22 The Arizona Board Of Regents On Behalf Of The University Of Arizona In vitro cellular bioassay for neurotoxicity testing
FR3021318B1 (fr) * 2014-05-20 2017-04-28 Inst Biophytis Produits derives de la 20-hydroxyecdysone et leur utilisation dans la preparation de medicaments
US9700589B2 (en) * 2015-02-03 2017-07-11 Naturex Sa Compositions and methods for improved muscle metabolism
FR3065644B1 (fr) * 2017-04-28 2020-02-21 Biophytis Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation

Also Published As

Publication number Publication date
US20200179407A1 (en) 2020-06-11
US11542295B2 (en) 2023-01-03
FR3065642A1 (fr) 2018-11-02
EP3615036B1 (fr) 2023-11-22
PT3615035T (pt) 2021-08-20
WO2018197708A1 (fr) 2018-11-01
ES2882571T3 (es) 2021-12-02
CN110769832A (zh) 2020-02-07
KR20200012871A (ko) 2020-02-05
JP7165143B2 (ja) 2022-11-02
KR20200005574A (ko) 2020-01-15
PT3615036T (pt) 2024-02-27
FR3065644B1 (fr) 2020-02-21
FR3065642B1 (fr) 2020-02-28
BR112019022379A2 (pt) 2020-05-19
WO2018197731A1 (fr) 2018-11-01
EP3615035A1 (fr) 2020-03-04
BR112019022392A2 (pt) 2020-05-19
KR102652803B1 (ko) 2024-04-01
KR102593901B1 (ko) 2023-10-26
JP7295806B2 (ja) 2023-06-21
JP2020517712A (ja) 2020-06-18
CN110769832B (zh) 2023-08-01
EP3615036A1 (fr) 2020-03-04
JP2020517697A (ja) 2020-06-18
DK3615036T3 (da) 2024-02-12
EP3615035B1 (fr) 2021-06-09
CN110753547A (zh) 2020-02-04
US20200148718A1 (en) 2020-05-14
FR3065644A1 (fr) 2018-11-02

Similar Documents

Publication Publication Date Title
PT3615035T (pt) Utilização de 20-hidroxiecdisona e os seus derivados no tratamento de miopatias
IL268210A (en) Use of gaboxadol in the treatment of tinnitus
ZA201904966B (en) Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
ZA201904967B (en) Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer
DK3681857T3 (en) Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
IL272414A (en) Use of gaboksadol in the treatment of diabetes and related conditions
IL266128B (en) History of naphthyridinone and its use in the treatment of arrhythmia
IL281495A (en) Quinuclidine-3-one derivatives and their use in cancer treatment
IL282527A (en) 5-Azaindazole history and their use
ZA201903828B (en) Novel glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases
PT3568397T (pt) Compostos e a sua utilização no tratamento da esquistossomose
IL282526A (en) 5-Azaindazole history and their use
IL274868A (en) History of imidazopyridine and their use as medicine
SG11202105137RA (en) Application of chidamide in combination with r-chop, and drug combination
IL282142A (en) The history of 4-pyrazine-2-ylmethyl-morpholine and its use as a medicine
EP3749332A4 (en) COMPOSITIONS AND THEIR USE IN THE TREATMENT OF ENDOMETRIOSIS AND PAIN
EP3648789C0 (en) MTMR2-S POLYPEPTIDE FOR USE IN THE TREATMENT OF MYOPATHY
AU2018900412A0 (en) Compositions and their use in the treatment of endometriosis and pain